|
SUNDAY,
SEPTEMBER 29, 2002 |
MONDAY,
SEPTEMBER 30, 2002 |
TUESDAY,
OCTOBER 1, 2002 |
WEDNESDAY,
OCTOBER 2, 2002 |
THURSDAY,
OCTOBER 3, 2002 |
| Orals |
Orals
|
Posters |
Orals
|
Posters |
Orals
|
Posters
|
Orals
|
Posters
|
| TUESDAY, OCTOBER 1, 2002 |
| 08:30 - 09:15 |
Hall A |
| PLENARY SESSION:
SYSTEMIC INVOLVEMENT IN APS |
Chairpersons:
|
M. Petri, USA
J. Peter, USA
J. Scali, Argentina |
| 08:30 |
EVIDENCE-BASED CLASSIFICATION CRITERIA FOR
APS
M. Petri, USA |
| 08:45 |
SYSTEMIC THROMBOEMBOLISM IN APS - WHAT DO WE
KNOW, WHAT IS UNKNOWN?
R. Derksen, The Netherlands |
| 09:00 |
CARDIAC
DISEASE IN APS/SLE
M.D. Lockshin, USA |
| |
| 09:15 - 10:50 |
Hall A |
| PATHOGENIC MECHANISMS II |
| Supported by an unrestricted
educational grant from La Jolla Pharmaceuticals, USA |
Chairpersons:
|
S.A. Krilis, Australia
R.A. Levy, Brazil |
| 09:15 |
ROLE
OF B2GPI-DEPENDENT aPL ON ARTERIAL THROMBOSIS
J. Arnout, M. Jankowski, M. Hoylaerts, D. Boon, I.
Vreys, J. Vermylen, Poland |
| 09:30 |
A
NOVEL FUNCTION OF B2GPI. IMPLICATIONS FOR THE APS
S.A. Krilis, W. Damcevski, K. Matthaei, Y.X. Wang,
T. Rithwell, Australia |
| 09:45 |
VENOUS
VS. ARTERIOLAR APS SUBSETS
J-C. Piette, France |
| 10:00 |
WHAT
IS LUPUS ANTICOAGULANT
T. Atsumi, T. Koike, Japan |
| 10:15 |
ANTI-B2GPI
ANTIBODIES FROM PATIENTS WITH APS ENHANCE BUDDING OF PHOSPHOLIPID
MEMBRANES
A. Ambrozic, S. Svetina, J. Majhenc, V. Arrigler, B.
Bozic, T. Kveder, Slovenia |
| 10:25 |
HOW
CAN DENTAL METALS INFLUENCE THE HEALTH IN PATIENTS WITH ANTIPHOSPHOLIPID
ANTIBODIES
J. Prochazkova, S. Podzimek, H. Kucerova, J. Bartova,
I. Sterzl,
Z. Ulcova-Gallova, V.D.M. Stejskal, Czech Republic, Sweden |
| 10:35 |
REGULATION
OF PHOSPHOLIPID BIOSYNTHESIS
S. Jackowski, USA |
| 10:45 |
DISCUSSION |
10:50 Coffee Break, Poster
Viewing and Exhibition Visit
|
| |
| 11:15 - 13:15 |
Hall A |
| CNS INVOLVEMENT
IN APS |
| Supported by an unrestricted
educational grant from Pharmacia Diagnostics, Germany |
Chairpersons:
|
R.L. Brey, USA
S.R. Levine, USA |
| 11:15 |
aPL
AND STROKE STUDY (APASS)
S.R. Levine, R.L. Brey, B.C. Tilley, J.L.T. Thompson,
R.L. Sacco,
T.M. Costigan, C. Rhine, A. Murphy, B. Levin, R.R. Sciacca,
D.A. Triplett,
J.P. Mohr, USA |
| 11:35 |
aPL
AND THE BRAIN: TREATMENT
R.L. Brey, S.R. Levine, USA |
| 11:55 |
CEREBROVASCULAR
DISEASE AND PHOSPHOLIPID ANTIBODIES:
A REVIEW INCLUDING DISAPPEARING ANTIBODIES
P.A. Gatenby, C.A. Hawkins, R.R. Tuck, G. Danta, C.J.
Andrews, Australia |
| 12:05 |
SNEDDON'S
SYNDROME IS A DISTINCT ENTITY FROM APS
G. Obermoser, G. Margreiter, M. Abenthung, N. Sepp,
Austria |
| 12:15 |
SNEDDON'S
SYNDROME AND SLE WITH CEREBROVASCULAR DISEASE AND LIVEDO RETICULARIS
L. Kalashnikova, S. Lozhnikova, L. Dobrynina, T. Reshetnyak,
E. Alexandrova, E. Nassonov, Russia |
| 12:25 |
SERUM
ANTIBODIES FROM PATIENTS WITH ELEVATED aPLS REACT DIRECTLY
WITH HUMAN BRAIN
M.N. Kent, M. Adineh, B. Ezzeddine, T.L. Vollmer, N.S.
Rote,
A. Coni-Kelly, T.P. Greco, USA |
| 12:35 |
PERIPHERAL
NEUROPATHY IN PATIENTS WITH PAPS
L. Kalashnikova, S. Lozhnikova, L. Dobrynina, N. Savizkaya,
E. Alexandrova, E. Nassonov, Russia |
| 12:45 |
COGNITIVE
FUNCTIONING IN SLE PATIENTS WITH THE APS
S.L. Holliday, D. Hermosillo Romo, A. Saklad, R.L. Brey,
USA |
| 12:55 |
ESTABLISHING
NORMAL RANGES FOR CEREBRAL SPINAL FLUID (CSF): DETERMINATIONS
OF aCL, aPS, aPE AND aPC
D.R. Wagenknecht, D.K. Sokol, J.A. McIntyre, USA |
13:05  |
LOW
MOLECULAR WEIGHT HEPARIN BUT NOT ASPIRIN AMELIORATES THE BEHAVIORAL
HYPERACTIVITY IN AN EXPERIMENTAL MODEL OF APS
A. Katzav, C.G. Pick, A.D. Korczyn, M. Blank, Y. Shoenfeld,
J. Chapman, Israel |
13:15 Lunch Break, Poster Viewing
and Exhibition Visit
|
SUNDAY,
SEPTEMBER 29, 2002 |
MONDAY,
SEPTEMBER 30, 2002 |
TUESDAY,
OCTOBER 1, 2002 |
WEDNESDAY,
OCTOBER 2, 2002 |
THURSDAY,
OCTOBER 3, 2002 |
| Orals |
Orals
|
Posters |
Orals
|
Posters |
Orals
|
Posters
|
Orals
|
Posters
|
|
|
